| 摘要 |
The invention relates to substituted phenylquinazoline derivatives. It concerns the compounds of formula I <CHEM> wherein the substituents have various significances. They may be obtained by a process comprising dehydration, ring closure and/or alkylation, and optional recovery in racemic or optically active, in free base or acid addition salt form. They possess pharmacological activity, in particular,they raise the blood serum high density lipoprotein level and are thus indicated for use in the treatment of atherosclerosis. |
